Back to News
Market Impact: 0.8

Israel’s attack and the limits of Iran’s missile strategy

Geopolitics & WarInfrastructure & DefenseSanctions & Export Controls
Israel’s attack and the limits of Iran’s missile strategy

Following escalating tensions, Israel launched a large-scale attack on Iran's nuclear program and military capabilities, targeting missile sites and key commanders, reportedly destroying a third of Iran's missile launchers. Iran retaliated with missile strikes, but the scale and effectiveness were limited compared to previous attacks, possibly due to Israeli interdiction and targeted assassinations. The conflict has exposed weaknesses in Iran's military strategy and eroded its deterrence posture, as its missile capabilities have been degraded and its adversaries' risk tolerance has increased.

Analysis

A large-scale Israeli attack on Iranian nuclear and military assets, commencing 13 June 2025, has significantly degraded Tehran's offensive capabilities, reportedly destroying approximately one-third of its pre-war missile launcher inventory and targeting key military commanders. Iran's retaliatory missile strikes, totaling around 370 ballistic missiles by 16 June, were notably smaller in scale than its October 2024 operations, potentially due to Israeli interdiction efforts, disruption of command and control from targeted assassinations, and other non-kinetic measures. Despite the reduced volume, Iranian attacks resulted in significantly higher Israeli casualties (23 killed, over 600 injured) due to a shift towards targeting more densely populated urban areas like Tel Aviv and Haifa, possibly indicating a move towards countervalue targeting or a response to perceived Israeli attacks on its own urban centers. Iran's medium-range ballistic missile arsenal, estimated at around 2,000 operational missiles (excluding short-range systems unable to reach Israel) prior to recent losses, faces limitations in accuracy and replenishment, with a pre-conflict production capacity of approximately 50 missiles per month insufficient to sustain current engagement rates, especially as Israel reportedly expands strikes to include Iranian missile production infrastructure. This military degradation, compounded by the prior weakening of regional allies like Lebanese Hizbullah and the limited strategic impact of Houthi attacks, has severely eroded Iran's deterrence posture, which traditionally relied on the threat of missile retaliation. The conflict underscores a critical shift in the regional security dynamic, with Israel demonstrating an increased risk tolerance following the 7 October 2023 attacks, challenging the long-standing deterrence balance. Iran may now consider alternative escalation pathways, such as targeting Israeli critical infrastructure or U.S. assets in the Gulf, though these options carry substantial risks of further escalation and alienating regional partners.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

moderately negative

Sentiment Score

-0.60

Key Decisions for Investors

  • Investors should anticipate heightened geopolitical volatility in the Middle East, with potential for significant disruptions to energy markets if Iran targets oil infrastructure or key shipping lanes like the Strait of Hormuz.
  • The conflict underscores the increasing importance of advanced missile defense systems and offensive strike capabilities, potentially creating opportunities in the aerospace and defense sectors, although specific beneficiaries are not identified.
  • Monitor for further escalation triggers, including Iranian attacks on critical energy infrastructure, U.S. military assets, or a sustained shift to countervalue targeting by Iran, which could lead to a broader regional conflict and severe market reactions.
  • Re-evaluate exposure to assets sensitive to Middle Eastern stability and consider portfolio hedging strategies in light of the unravelling deterrence between Israel and Iran and Israel's elevated risk tolerance.